| 000 | 01364 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250514012406.0 | ||
| 264 | 0 | _c20011025 | |
| 008 | 200110s 0 0 eng d | ||
| 022 | _a0093-7754 | ||
| 024 | 7 |
_a10.1016/s0093-7754(01)90058-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRosell, R | |
| 245 | 0 | 0 |
_aPredicting response to paclitaxel/carboplatin-based therapy in non-small cell lung cancer. _h[electronic resource] |
| 260 |
_bSeminars in oncology _cAug 2001 |
||
| 300 |
_a37-44 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aCarboplatin _xadministration & dosage |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aDNA, Neoplasm _xblood |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 |
_aTubulin _xgenetics |
| 700 | 1 | _aFelip, E | |
| 773 | 0 |
_tSeminars in oncology _gvol. 28 _gno. 4 Suppl 14 _gp. 37-44 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0093-7754(01)90058-2 _zAvailable from publisher's website |
| 999 |
_c11524738 _d11524738 |
||